Dexamethasone treatment of common diabetic eye condition.

NICE is recommending dexamethasone (Ozurdex, Allergan) intravitreal(1) implant, for the treatment of diabetic macular oedema (DMO) in preliminary recommendations published 20/02/ 2015.

The draft guidance recommends dexamethasone as a treatment option in people only where:

  •  the implant is to be used in an eye with an intraocular (pseudophakic)(2) lens,  and
  •  their diabetic macular oedema does not respond to non-corticosteroid(3) treatment or such a treatment is unsuitable for them.

Leave a Comment

I accept the Privacy Policy

This site uses Akismet to reduce spam. Learn how your comment data is processed.